However, in contrast to these protective and regenerative effects of ILC-22, Longman et al. found that colonic ILC3 from UC as well as CD patients showed an increased IL-22 production capacity [51] and a study using the anti-CD40 model of innate colitis found a pathogenic role for IL-22 [63]. Here, IL22 is linked to colitis.